Characterization of ATP-induced cell death in the GL261 mouse glioma

Journal of Cellular Biochemistry

Volumn 109, Issue 5, 2010, Pages 983-991

  Tamajusuku, Alessandra S K ^a   Villodre, Emilly S ^a   Paulus, Romela ^a   Coutinho Silva, Robson ^b   Battasstini, Ana M O ^a   Wink, Márcia R ^c   Lenz, Guido ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Glioblastoma multiforme; Glioma; Necrosis; P2X7; Purinoceptor

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; RNA; URIDINE TRIPHOSPHATE;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL PERMEABILIZATION; CELL SUBPOPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL DEATH; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOMA; MICE; NECROSIS; RECEPTORS, PURINERGIC P2;

MURINAE; RATTUS;

EID: 77950373387     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22478     Document Type: Article

References (40)

1. Andrade CMB, Roesch GC, Wink MR, Guimarães EML, Souza LF, Jardim FR, Guaragna RM, Bernard EA, Margis R, Borojevic R, Battastini AMO, Guma FCR. 2008. Activity and expression of ecto-5'-nucleotidase/CD73 are increased during phenotype conversion of a hepatic cell line. Life Sci 82: 21-29.
2. Arcella A, Carpinelli G, Battaglia G, D'Onofrio M, Santoro F, Ngomba RT, Bruno V, Casolini P, Giangaspero F, Nicoletti F. 2005. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo. Neuro-oncology 7:236-245.
3. Auger R, Motta I, Benihoud K, Ojcius DM, Kanellopoulos JM. 2005. A role for mitogen-activated protein kinase(Erk1/2) activation and non-selective pore formation in P2X7 receptor-mediated thymocyte death. J Biol Chem 280:28142-28151.
4. Braganhol E, Morrone FB, Bernardi A, Huppes D, Meurer L, Edelweiss MI, Lenz G, Wink MR, Robson SC, Battastini AM. 2009. Selective NTPDase2 expression modulates in vivo rat glioma growth. Cancer Sci 100:1434-1442.
5. Burnstock G. 2006. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58-86.
6. Cavaliere F, Amadio S, Sancesario G, Bernardi G, Volonte C. 2004. Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures. J Cereb Blood Flow Metab 24:392-398.
7. Cavaliere F, Amadio S, Dinkel K, Reymann KG, Volonte C. 2007. P2 receptor antagonist trinitrophenyl-adenosine-triphosphate protects hippocampus from oxygen and glucose deprivation cell death. J Pharmacol Exp Ther 323:70-77.
8. Chen L, Brosnan CF. 2006. Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: Evidence for loss of apoptotic activity in lymphocytes. J Immunol 176:3115-3126.
9. Coutinho-Silva R, Stahl L, Cheung KK, de Campos NE, de Oliveira Souza C, Ojcius DM, Burnstock G. 2005. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: Effects of extracellular nucleotides on apoptosis and cell proliferation. Am J Physiol Gastrointest Liver Physiol 288:G1024-G1035.
10. Delarasse C, Gonnord P, Galante M, Auger R, Daniel H, Motta I, Kanellopoulos JM. 2009. Neural progenitor cell death is induced by extracellular ATP via ligation of P2X7 receptor. J Neurochem 109:846-857.
11. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. 1998. A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463-8471.
12. Greenberg S, Di Virgilio F, Steinberg TH, Silverstein SC. 1988. Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. J Biol Chem 263:10337-10343.
13. Greig AV, Linge C, Healy V, Lim P, Clayton E, Rustin MH, McGrouther DA, Burnstock G. 2003. Expression of purinergic receptors in non-melanoma skin cancers and their functional roles in A431 cells. J Invest Dermatol 121:315-327.
14. Jacques-Silva MC, Rodnight R, Lenz G, Liao Z, Kong Q, Tran M, Kang Y, Gonzalez FA, Weisman GA, Neary JT. 2004. P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br J Pharmacol 141:1106-1117.
15. Jun DJ, Kim J, Jung SY, Song R, Noh JH, Park YS, Ryu SH, Kim JH, Kong YY, Chung JM, Kim KT. 2007. Extracellular ATP mediates necrotic cell swelling in SN4741 dopaminergic neurons through P2X7 receptors. J Biol Chem 282:37350-37358.
16. Le Feuvre RA, Brough D, Touzani O, Rothwell NJ. 2003. Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J Cereb Blood Flow Metab 23:381-384.
17. Lenz G, Gottfried C, Luo Z, Avruch J, Rodnight R, Nie WJ, Kang Y, Neary JT. 2000. P(2Y) purinoceptor subtypes recruit different mek activators in astrocytes. Br J Pharmacol 129:927-936.
18. Lenz G, Goncalves D, Luo Z, Avruch J, Rodnight R, Neary JT. 2001. Extracellular ATP stimulates an inhibitory pathway towards growth factor-induced cRaf-1 and MEKK activation in astrocyte cultures. J Neurochem 77:1001-1009.
19. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
20. Mackenzie AB, Young MT, Adinolfi E, Surprenant A. 2005. Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J Biol Chem 280:33968-33976.
21. Morrone FB, Jacques-Silva MC, Horn AP, Bernardi A, Schwartsmann G, Rodnight R, Lenz G. 2003. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines. J Neurooncol 64:211-218.
22. Morrone FB, Horn AP, Stella J, Spiller F, Sarkis JJ, Salbego CG, Lenz G, Battastini AM. 2005. Increased resistance of glioma cell lines to extracellular ATP cytotoxicity. J Neurooncol 71:135-140.
23. Morrone FB, Oliveira DL, Gamermann P, Stella J, Wofchuk S, Wink MR, Meurer L, Edelweiss MI, Lenz G, Battastini AM. 2006. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer 6:226.
24. Okada H, Mak TW. 2004. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 4:592-603.
25. Pelegrin P, Surprenant A. 2006. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25:5071-5082.
26. Peterson GL. 1983. Determination of total protein. Methods Enzymol 91:95-119.
27. Raffaghello L, Chiozzi P, Falzoni S, Di Virgilio F, Pistoia V. 2006. The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res 66:907-914.
28. Shih AH, Holland EC. 2004. Developmental neurobiology and the origin of brain tumors. J Neurooncol 70:125-136.
29. Slater M, Danieletto S, Gidley-Baird A, Teh LC, Barden JA. 2004a. Early prostate cancer detected using expression of non-functional cytolytic P2X7 receptors. Histopathology 44:206-215.
30. Slater M, Danieletto S, Pooley M, Cheng Teh L, Gidley-Baird A, Barden JA. 2004b. Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res Treat 83:1-10.
31. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735-738.
32. Szatmari T, Lumniczky K, Desaknai S, Trajcevski S, Hidvegi EJ, Hamada H, Safrany G. 2006. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci 97:546-553.
33. Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M. 2001. Glutamate release promotes growth of malignant gliomas. Nat Med 7:1010-1015.
34. Takenouchi T, Nakai M, Iwamaru Y, Sugama S, Tsukimoto M, Fujita M, Wei J, Sekigawa A, Sato M, Kojima S, Kitani H, Hashimoto M. 2009. The activation of P2X7 receptor impairs lysosomal functions and stimulates the release of autophagolysosomes in microglial cells. J Immunol 182:2051-2062.
35. Taylor SR, Gonzalez-Begne M, Dewhurst S, Chimini G, Higgins CF, Melvin JE, Elliott JI. 2008. Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J Immunol 180:300-308.
36. The-Cancer-Genome-Atlas. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068.
37. Tsukimoto M, Harada H, Ikari A, Takagi K. 2005. Involvement of chloride in apoptotic cell death induced by activation of ATP-sensitive P2X7 purinoceptor. J Biol Chem 280:2653-2658.
38. Wang X, Arcuino G, Takano T, Lin J, Peng WG, Wan P, Li P, Xu Q, Liu QS, Goldman SA, Nedergaard M. 2004. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10:821-827.
39. Wink MR, Lenz G, Braganhol E, Tamajusuku AS, Schwartsmann G, Sarkis JJ, Battastini AM. 2003. Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Lett 198:211-218.
40. Young MT, Pelegrin P, Surprenant A. 2007. Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP. Mol Pharmacol 71:92-100.